Rapid evolution of the neutralizing antibody response to HIV type 1 infectionDouglas D. Richman, Christos J. Petropoulos, Terri Wrin et al.|Proceedings of the National Academy of Sciences|2003Cited by 1.2k
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Joanna Donatelli et al.|Cell Reports|2021Cited by 266
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Saki Takahashi et al.|Science Advances|2021Cited by 150
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infectionBerta Rodés, Vincent Soriano, Carlos Toro et al.|AIDS|2004Cited by 115